# Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

> **NCT01391390** · NA · COMPLETED · sponsor: **Beijing HuiLongGuan Hospital** · enrollment: 120 (actual)

## Conditions studied

- Tardive Dyskinesia

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01391390
- **Lead sponsor:** Beijing HuiLongGuan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01391390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01391390, "Melatonin Treatment for Tardive Dyskinesia in Schizophrenia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01391390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*